Depression in patients with hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 4, 2013, Pages 473-478

  Onderdijk, A J ^a,b   Van Der Zee, H H ^b   Esmann, S ^c   Lophaven, S ^d   Dufour, D N ^c   Jemec, G B E ^c   Boer, J ^a  

^a Deventer Hospital   (Denmark)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Statistical Consultant ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MAJOR DEPRESSION INVENTORY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; QUALITY OF LIFE; SUPPURATIVE HIDRADENITIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; DEPRESSION; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84875365969     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04468.x     Document Type: Article

References (21)

1. Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455-456.
2. Jemec GB, Heidenheim M, Nielsen NH,. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191-194.
3. Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596-601.
4. Jemec GB,. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47-56.
5. Yazdanyar S, Jemec GB,. Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis 2011; 24: 118-123.
6. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J,. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623.
7. von der Werth JM, Jemec GB,. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-813.
8. Matusiak U, Bieniek A, Szepietowski JC,. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90: 264-268.
9. Matusiak L, Bieniek A, Szepietowski JC,. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706-708.
10. Esmann S, Jemec GB,. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 2011; 91: 328-332.
11. Jemec GB, Heidenheim M, Nielsen NH,. Hidradenitis suppurativa- characteristics and consequences. Clin Exp Dermatol 1996; 21: 419-423.
12. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
13. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W,. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 3: 159-164.
14. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P,. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33: 351-356.
15. Hurley HJ,. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In:, Roenigk RK, Roenigk HH, editors. Dermatologic Surgery, Principles and Practice. Marcel Dekker, New York, 1989: 732-739.
16. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY,. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
17. Esmann S, Jemec GB,. Is the Dermatology Life Quality Index really time-sensitive? J Eur Acad Dermatol Venereol 2010; 24: 621-622.
18. Olsen LR, Mortensen EL, Bech P,. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 2004; 109: 96-103.
19. Ernstmann N, Neumann M, Ommen O, et al. Determinants and implications of cancer patients' psychosocial needs. Support Care Cancer 2009; 17: 1417-1423.
20. Taylor L, Wicks P, Leigh PN, Goldstein LH,. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol 2010; 17: 1047-1053.
21. Jemec GB, Wendelboe P,. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971-974.